OPM is a technological company specialized in precision medicine.
OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.
For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.
To discuss partnership or investment, don't hesitate to get in touch : info@oncodesign.com
Company Details
- Employees
- 17
- Founded
- -
- Address
- 18, Rue Jean Mazen, Dijon,bourgogne-Franche-Comté 21000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.oncodesign.com
- Keywords
- precision medicine, drug discovery, oncology, target identification, theranostic, vector of innovation.
- HQ
- Dijon, Bourgogne-Franche-Comté
Oncodesign Precision Medicine - Opm Questions
Oncodesign Precision Medicine - Opm's website is http://www.oncodesign.com
Oncodesign Precision Medicine - Opm's LinkedIn profile is https://fr.linkedin.com/company/oncodesign-precision-medicine
Oncodesign Precision Medicine - Opm has
17 employees.
View email and phone details for 17
employees at Oncodesign Precision Medicine - Opm.
Oncodesign Precision Medicine - Opm's industry is
Biotechnology Research
Oncodesign Precision Medicine - Opm's top competitors are
Phaxiam Therapeutics,
Parean Biotechnologies,
Innate Pharma,
Cellectis,
Quintessence Biotech,
Ose Immunotherapeutics,
Flowstim Technology,
Fc'innov,
Promethe.eu,
Oncodesign Services.
Oncodesign Precision Medicine - Opm's categories are Biotechnology Research
Oncodesign Precision Medicine - Opm's founding year is 2022
